BaroFold Announces New Patent Issuance.BOULDER Boulder, city, United States Boulder, city (1990 pop. 83,312), seat of Boulder co., N central Colo.; inc. 1871. A Rocky Mountain resort and a suburb of Denver, it is the seat of the Univ. of Colorado (1876). , Colo. -- BaroFold, Inc. announced today the issuance of United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. Patent 7,064,192 B2 covering the High Pressure Refolding of Protein Aggregates and Inclusion Bodies. This patent covers technology which provides an effective method for the refolding of proteins so that properly folded, biologically active protein is recovered in high yield. The method can be applied to substantially all proteins, including soluble soluble /sol·u·ble/ (sol´u-b'l) susceptible of being dissolved. sol·u·ble adj. Capable of being dissolved, especially easily dissolved. aggregates, inclusion bodies, and insoluble insoluble /in·sol·u·ble/ (in-sol´u-b'l) not susceptible of being dissolved. in·sol·u·ble adj. Not soluble. aggregates. "We are pleased with the confirmation of the proprietary technology that we have developed," said Lyndal Hesterberg, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of BaroFold Inc. "This patent expands BaroFold's IP portfolio in the area of therapeutic protein refolding and is central to our current commercial success as well as our development as a fully integrated therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. company." About BaroFold BaroFold's patented PreEMT(TM) technology has the potential to provide safer follow-on and proprietary protein therapeutics at lower cost than traditional biologicals. BaroFold technology enables production of challenging proteins at research or commercial scale thus enabling research and discovery leading to both protein and small molecule therapeutics. The Company leverages its technology through partnerships with research facilities, major biotechnology and pharmaceutical companies. For additional information about the company, please visit http://www.barofold.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion